Literature DB >> 33419253

The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells.

Éva Márton1, Alexandra Varga1, Lajos Széles1, Lóránd Göczi1, András Penyige1,2, Bálint Nagy1, Melinda Szilágyi1.   

Abstract

Exposure to physiological estrogens or xenoestrogens (e.g., zearalenone or bisphenol A) increases the risk for cancer. However, little information is available on their significance in ovarian cancer. We present a comprehensive study on the effect of estradiol, zearalenone and bisphenol A on the phenotype, mRNA, intracellular and cell-free miRNA expression of human epithelial ovarian cell lines. Estrogens induced a comparable effect on the rate of cell proliferation and migration as well as on the expression of estrogen-responsive genes (GREB1, CA12, DEPTOR, RBBP8) in the estrogen receptor α (ERα)-expressing PEO1 cell line, which was not observable in the absence of this receptor (in A2780 cells). The basal intracellular and cell-free expression of miR200s and miR203a was higher in PEO1, which was accompanied with low ZEB1 and high E-cadherin expression. These miRNAs showed a rapid but intermittent upregulation in response to estrogens that was diminished by an ERα-specific antagonist. The role of ERα in the regulation of the MIR200B-MIR200A-MIR429 locus was further supported by publicly available ChIP-seq data. MiRNA expression of cell lysates correlated well with cell-free miRNA expression. We conclude that cell-free miR200s might be promising biomarkers to assess estrogen sensitivity of ovarian cells.

Entities:  

Keywords:  EMT; bisphenol A; cell-free miRNA; estrogen; estrogen receptor; miR200; miR203a; ovarian cancer; zeralenone

Mesh:

Substances:

Year:  2020        PMID: 33419253      PMCID: PMC7766742          DOI: 10.3390/ijms21249725

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  77 in total

1.  Zearalenone regulates endometrial stromal cell apoptosis and migration via the promotion of mitochondrial fission by activation of the JNK/Drp1 pathway.

Authors:  Huixiang Wang; Xiaoli Zhao; Chengxiang Ni; Yuyang Dai; Yan Guo
Journal:  Mol Med Rep       Date:  2018-03-29       Impact factor: 2.952

Review 2.  Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.

Authors:  Maria Koutsaki; Demetrios A Spandidos; Apostolos Zaravinos
Journal:  Cancer Lett       Date:  2014-06-18       Impact factor: 8.679

3.  Antagonists selective for estrogen receptor alpha.

Authors:  Jun Sun; Ying R Huang; William R Harrington; Shubin Sheng; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

4.  Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.

Authors:  Xia Ren; Xuan Wu; Stephen G Hillier; K Scott Fegan; Hilary O D Critchley; J Ian Mason; Sana Sarvi; Christopher R Harlow
Journal:  J Steroid Biochem Mol Biol       Date:  2015-03-24       Impact factor: 4.292

5.  Prognostic value of CtIP/RBBP8 expression in breast cancer.

Authors:  Isabel Soria-Bretones; Carmen Sáez; Manuel Ruíz-Borrego; Miguel A Japón; Pablo Huertas
Journal:  Cancer Med       Date:  2013-10-03       Impact factor: 4.452

Review 6.  Estrogen biosynthesis and action in ovarian cancer.

Authors:  Felicitas Mungenast; Theresia Thalhammer
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-12       Impact factor: 5.555

Review 7.  Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations.

Authors:  Ioannis A Voutsadakis
Journal:  Clin Med Insights Oncol       Date:  2016-03-29

Review 8.  Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer.

Authors:  Simon P Langdon; C Simon Herrington; Robert L Hollis; Charlie Gourley
Journal:  Cancers (Basel)       Date:  2020-06-22       Impact factor: 6.639

9.  GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer.

Authors:  Kendra Hodgkinson; Laura A Forrest; Nhung Vuong; Kenneth Garson; Bojana Djordjevic; Barbara C Vanderhyden
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

Review 10.  MicroRNAs: potential targets and agents of endocrine disruption in female reproduction.

Authors:  Reem Sabry; Jyoji Yamate; Laura Favetta; Jonathan LaMarre
Journal:  J Toxicol Pathol       Date:  2019-07-27       Impact factor: 1.628

View more
  1 in total

Review 1.  MicroRNA regulates the toxicological mechanism of four mycotoxins in vivo and in vitro.

Authors:  Jia Chen; Shuhua Yang; Peng Li; Aibo Wu; Eugenie Nepovimova; Miao Long; Wenda Wu; Kamil Kuca
Journal:  J Anim Sci Biotechnol       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.